Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,341 total articles
EverCommerce Inc. President Matthew David Feierstein sold 15,000 shares of company common stock on March 4 and 5, 2026, totaling $181,169. The transactions were executed under a Rule 10b5-1 trading plan put in place August 20, 2025. Following the sales and a tax-withholding disposition, Feierstein retains substantial direct and indirect holdings in…
Nuveen Quality Municipal Income Fund (NYSE:NAD) Vice President William A. Siffermann purchased 100 shares on March 5, 2026, paying $12.0562 per share for a total outlay of $1,205. The purchase was disclosed in a Form 4 filed with the SEC on March 6, 2026. After the trade, Siffermann directly owns 1,041.3222 shares. The fund is trading close to its …
Bank of America Chief Operations Executive Thomas M. Scrivener sold 50,000 shares on March 5, 2026, generating $2.49 million in proceeds. The transaction occurred at prices between $49.82 and $49.83, modestly above the prevailing share price. The sale coincides with a series of corporate financing and strategic moves by the bank, including a planne…
Dave Inc. director Andrea Mitchell sold 29,160 shares of Class A common stock on March 5 and 6, 2026, under a Rule 10b5-1 trading plan, generating proceeds of $6.3 million. The sales come as the fintech prepares a $150 million convertible notes placement, reports stronger-than-expected Q4 2025 results and receives multiple analyst coverage actions.
Alphabet Inc. CEO Sundar Pichai completed $9.8 million in Class C stock sales on March 4, 2026, while acquiring zero-valued Google Stock Units and maintaining substantial direct and indirect holdings. The trades were carried out under a Rule 10b5-1 plan adopted in December 2024. The filings coincide with corporate updates on executive pay and sever…
Robert F. Hoffman, Century Aluminum Co's senior vice president of IT and chief accounting officer, sold 10,000 shares on March 4, 2026, for $563,300. The sale occurred near the stock's 52-week high while the company reported fourth-quarter 2025 EBITDA in line with expectations and pursued a large joint venture to expand U.S. primary aluminum capaci…
Perimeter Solutions director William N. Thorndike Jr. sold 325,000 shares of common stock across three trades from March 4-6, 2026, generating $7,801,500 in proceeds. The transactions, disclosed on a Form 4 filing, leave Thorndike with 8,860,656 shares directly held. The sales occurred as the stock sits near the director's average sale prices after…
A TransMedics Group, Inc. director liquidated a small block of shares worth $178,496 on March 4, 2026, even as the company delivered robust fourth-quarter results and issued 2026 revenue guidance that modestly exceeded analyst expectations. The transaction reduced the director's direct holdings to 2,866 shares. Separately, TransMedics reported a ma…
Krishnan Krish S, President and CEO of Krystal Biotech, executed multiple share sales totaling 23,870 shares on March 4, 2026, producing roughly $6.58 million in proceeds. The trades were carried out under an existing Rule 10b5-1 trading arrangement. The stock is trading below an InvestingPro Fair Value estimate even after notable six-month gains a…
Ligand Pharmaceuticals' Chief Financial Officer, Octavio Espinoza, sold 11,223 shares on March 4, 2026, netting roughly $2.76 million under a pre-established Rule 10b5-1 plan while also exercising options. The trades coincide with the stock trading close to its 52-week high after a strong one-year performance, and follow robust fourth-quarter and f…
Andrew Reardon, Chief Legal Officer and Secretary of Ligand Pharmaceuticals (LGND), sold 4,858 shares on March 4, 2026, for roughly $1.03 million and exercised options to buy 5,000 shares at $52.27. The trades were carried out under a pre-arranged trading plan. Separately, Ligand posted fourth-quarter and full-year 2025 results that beat analysts' …
Rodney Clemente, Senior Vice President for Water at Energy Recovery, Inc. (NASDAQ: ERII), sold 20,568 shares on March 4, 2026, for $218,308 under a pre-arranged Rule 10b5-1 trading plan, according to a Form 4 filing. The transaction occurred as ERII shares traded near a 52-week low and followed a fourth-quarter 2025 earnings and revenue miss and a …
John P. Lauer, Executive Vice President and Chief Commercial Officer of Matson, Inc. (NYSE: MATX), sold 8,603 shares on March 5, 2026, generating $1,429,216 at $166.13 per share. The transaction occurred while the stock traded at $152.99 and after a 46% return over the prior six months. Matson also reported fourth-quarter adjusted EPS of $4.60, bea…
Mardi Dier, Executive Vice President and CFO of Madrigal Pharmaceuticals (MDGL), completed the sale of 1,962 shares on March 6, 2026 under a pre-arranged Rule 10b5-1 plan, generating about $854,000. The trades came alongside an earlier March 4 acquisition of 5,215 shares with a recorded value of $0 and a grant of options to buy 6,519 shares at $434…
StandardAero Chief Executive Ford Russell Wayne sold 40,000 shares on March 4, 2026, receiving $1,203,456 under a pre-established Rule 10b5-1 trading plan. The sale was processed indirectly through a Family LLC; following the transaction he indirectly holds 606,955 shares. The stock trades at $28.87, below the weighted average sale price of $30.086…
Emily Dreyer, Trupanion Inc.'s chief revenue officer, sold 7,792 shares of the company's common stock on March 4, 2026, generating $219,319 at an average price of $28.1468 per share. The sale occurred while the stock traded near its 52-week low of $25.24 and after a six-month decline of 38%. Dreyer retains direct ownership of 35,627 shares. Separat…
Natural Alternatives International Inc's chief executive and chairman, Mark A. LeDoux, purchased 1,250 shares of the company's common stock in three transactions between March 4 and March 6, 2026, at prices between $2.75 and $2.80 per share, for a total outlay of $3,474. The transactions were disclosed on a Form 4 filing with the Securities and Exc…
Tyrone Graham, Executive Vice President and Chief Human Resources Officer at Amalgamated Financial Corp (NASDAQ: AMAL), sold 501 shares on March 4, 2026, under a pre-established Rule 10b5-1 trading plan. The transaction totaled $19,478 at $38.88 per share. Following the sale Graham retained 15,538.56 shares. Separately, Amalgamated Financial report…
Rimini Street (RMNI) reported an automatic sell-to-cover transaction by Executive Vice President and Chief Revenue Officer Steven Hershkowitz on March 4, 2026, alongside simultaneous stock vesting events that increased his direct holdings. The sales, enacted to satisfy withholding tax obligations, did not originate from a discretionary decision by …
Elizabeth Krystyn, a member of Baldwin Insurance Group's 10% Owner Group, sold 120,000 Class A shares on March 6, 2026, for $2,549,723 at $21.25 per share. The transaction followed a conversion of 120,000 Class B shares into Class A shares at a conversion price of $0.0. Baldwin’s shares have suffered notable declines across multiple time horizons e…
Kevin Maddock, Executive Vice President and Chief Recurring Revenue Officer at Rimini Street, Inc. (NASDAQ:RMNI), was involved in automatic sell-to-cover stock sales on March 4, 2026, while simultaneously acquiring additional shares through the exercise of equity units. Separately, Rimini Street extended its ERP support engagement with Tidewater In…
Alclear Investments, LLC, a director and ten percent owner of Clear Secure, Inc. (NASDAQ: YOU), executed a series of transactions in early March 2026 that included the sale of 174,324 Class A shares for roughly $8.4 million and additional disposals and simultaneous acquisitions across Class A, B and D shares. The sales were made under a pre-establi…
Clear Secure CEO Caryn Seidman Becker sold 174,324 shares of Class A Common Stock on March 4, 2026, generating about $8.46 million. The trades took place as the company's stock traded close to its 52-week high and followed a quarter marked by revenue and bookings that beat the high end of guidance. Multiple brokerages raised price targets after the…
CoreWeave Chief Strategy Officer Brian M. Venturo, via West Clay Capital LLC, sold 334,950 Class A shares on March 4, 2026, for roughly $22.3 million under a Rule 10b5-1 plan. The stock has retreated from the sale range to $72.99, while the company reported 2025 revenue of $5.13 billion and announced a strategic partnership for AI inference workloa…
Delek Logistics Partners Executive Vice President Reuven Spiegel sold 250 common units on March 4, 2026, at $53.20 per unit for a total of $13,300. The transaction, executed under a pre-arranged 10b5-1 trading plan adopted March 6, 2025, leaves Spiegel with 22,490 common units. The company recently reported fourth-quarter 2025 results that fell sho…
